Zoom Logo

T32 Seminar Course - Shared screen with speaker view
shannanrich
01:30:13
How do you decide which (and how many) additional disease sequalae to include in a cost-effectiveness analysis?
Ashley Sanders
01:32:46
As a related question, particularly relevant in public health, and particularly relevant to treating chronic disease, but do you account for the added cost of care during added years of life?
Ashley Sanders
01:34:39
And the worth of a life also should be measured in opportunity cost. If we only have $X to spend should we ever spend it on expensive lives, or use it to save more less expensive lives
Natalie Chichetto
01:37:50
Great talk! I look forward to chatting over dinner.
Jillian Rung (she/her)
01:39:15
Thank you so much for presenting. Really important work and it was wonderful to hear you present it!